FARE - Food Allergy Research & Education Logo

Effect of Personalized Elimination Diet on Food Sensitivity Related Symptoms

Study Purpose

The goal is to identify food sensitivity in patients and assess whether the avoidance of the reaction-inducing foods via an 'elimination diet' leads to improvement in patient symptoms and overall well-being.

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Interventional
Eligible Ages 18 Years - 65 Years
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

  • - Patients aged between 18 to 65 years.
  • - Patients suffering from food sensitivity symptoms.
  • - Patients having Immunoglobulin G (IgG) and Immunoglobulin A (IgA)-mediated food reactions leading to food sensitivity.
  • - Patients agreeing to follow the diet per testing.
  • - Patients willing to provide an informed consent.

Exclusion Criteria:

  • - Patients suffering from chronic medical conditions like cancer.
  • - Pregnant subjects.
  • - Patients who have recently used antibiotics.
  • - Patients who have previously undergone treatments for food allergies/sensitivities.
  • - Patients who have been assigned an elimination diet before.
  • - Patients who are already following a restricted diet of any kind.
- Patients unwilling/unable to provide informed consent

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT05389683
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

N/A
Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

Vibrant America Clinical Lab
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

Hari K Krishnamurthy, M.S.
Principal Investigator Affiliation PI
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Industry
Overall Status Active, not recruiting
Countries United States
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Food Sensitivity
Additional Details

After seeking appropriate consent, patients' blood samples will be tested for the reactivity toward 262 foods using peptide and protein microarrays. Food protein extraction will be carried out in different solvents such as water and alcohol. The peptide microarrays will synthesize the entire food proteins as peptides in situ while the protein microarrays will test for water-soluble and alcohol-soluble fractions. Thus, food sensitivity testing will be carried out at 3 different levels including water-soluble proteins, alcohol-soluble proteins, and peptides. Patients' blood samples can be tested at all 3 levels or a combination of these. This decision lies at the discretion of the physician. Based on the test results and as per the physician's recommendations, a suitable elimination diet will be suggested to the patient. Personalized diet suggestions for each patient will be made by the physician. The patient will follow the diet for 4 weeks and blood samples will be tested again on completion of the diet, using peptides and protein microarrays. Additionally, based on the physician's recommendations, the time duration for which a patient follows the personalized elimination diet can be modified. The patients will periodically have to fill out diagnostic questionnaires which will help assess the changes in their food sensitivity-related symptoms. Changes in the blood biomarkers and improvement in symptoms will be monitored during the study.

Arms & Interventions

Arms

Experimental: Elimination Diet

Participants will be suggested an 'Elimination diet' that will be devoid of the reaction-inducing foods and it shall be followed for 4 weeks.

Interventions

Behavioral: - Elimination Diet

An 'elimination diet' devoid of the reaction-inducing foods will be suggested for 4 weeks.

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

Hope Natural Health, Gilbert, Arizona

Status

Address

Hope Natural Health

Gilbert, Arizona, 85298

Inside Out Aesthetics, Scottsdale, Arizona

Status

Address

Inside Out Aesthetics

Scottsdale, Arizona, 85254

Vitality MD's, Scottsdale, Arizona

Status

Address

Vitality MD's

Scottsdale, Arizona, 85258

Mr. Hari Krishnamurthy, San Carlos, California

Status

Address

Mr. Hari Krishnamurthy

San Carlos, California, 94070

Vitality Health and Wellness, Miami Beach, Florida

Status

Address

Vitality Health and Wellness

Miami Beach, Florida, 33139

Institute for Hormonal Balance, Orlando, Florida

Status

Address

Institute for Hormonal Balance

Orlando, Florida, 32819

One Agora Integrative Health, Bloomington, Minnesota

Status

Address

One Agora Integrative Health

Bloomington, Minnesota, 55431

Manheim, Pennsylvania

Status

Address

Turnpaugh Health and Wellness Center - Manheim

Manheim, Pennsylvania, 17545

Mechanicsburg, Pennsylvania

Status

Address

Turnpaugh Health and Wellness Center - Mechanicsburg

Mechanicsburg, Pennsylvania, 17050

The content provided on clinical trials is for informational purposes only and is not a substitute for medical consultation with your healthcare provider. We do not recommend or endorse any specific study and you are advised to discuss the information shown with your healthcare provider. While we believe the information presented on this website to be accurate at the time of writing, we do not guarantee that its contents are correct, complete, or applicable to any particular individual situation. We strongly encourage individuals to seek out appropriate medical advice and treatment from their physicians. We cannot guarantee the availability of any clinical trial listed and will not be responsible if you are considered ineligible to participate in a given clinical trial. We are also not liable for any injury arising as a result of participation.